ÂÜÀòÂÒÂ×

Dr. Rick L. Ryan serves as the Chief Executive Officer of Apertus Pharmaceuticals where he provides strategic direction to the company and its partnerships with pharmaceutical companies, venture capital firms, universities and research institutions. Rick has over 30 years experience in the life sciences industry including business management and new business/technology development. He has held executive leadership positions in multinational corporations as well as early stage ventures. Before joining Apertus, Rick was Vice President of the Drug Discovery & Development business unit at Millipore Corporation. He had P&L responsibility for DDD, which provided discovery and development products and services to Pharma and Biotech customers. At Millipore he also led innovation programs, such as biomarker applications for discovery, and development for companion diagnostic applications. Rick was formerly the President of LINCO Research Inc, which was acquired by Millipore in 2007. He started his biotechnology career at Monsanto, where he held several technology and business management positions of increasing responsibility, including Dir. Commercial/Business Development, Dir. Strategic Planning and Dir. International Markets. Rick received his PhD (Biochemistry) from the University of Illinois and his executive MBA from Washington University in St. Louis. He was an American Cancer Society post-doctoral fellow at the University of Wisconsin. He obtained his B.S. in chemistry from Central College of Iowa.